Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
OTHER INFECTIOUS DISEASES - ELISA
Adenovirus IgA |
ADVA0010/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Adenovirus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Adenovirus IgG |
ADVG0010/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Adenovirus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Adenovirus IgM |
ADVM0010/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Adenovirus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Bordetella pertussis- toxin IgA |
BOPA0030/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Bordetella pertussis toxin |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
Bordetella pertussis- toxin IgG |
BOPG0030/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Bordetella pertussis toxin |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Bordetella pertussis- toxin IgM |
BOPM0030/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Bordetella pertussis toxin |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Borrelia burgdorferi IgG |
BORG0040/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Borrelia burgdorferi |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Borrelia burgdorferi IgM |
BORM0040/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Borrelia burgdorferi |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Brucella IgG |
BRUG0050/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Brucella |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Brucella IgM |
BRUM0050/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Brucella |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Candida albicans IgA |
CANA0060/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Candida Albicans |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Candida albicans IgG |
CANAG0060/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Candida Albicans |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Candida albicans IgM |
CANAM0060/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Candida Albicans |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Chlamydia IgA Seroelisa |
P2840/96 Wells |
Intended use |
For the qualitative determination of IgA Antibodies to Chlamydia. |
Label |
HRP |
Method |
ELISA |
Controls included |
Three Controls (positive, low positive, negative) |
Incubations |
30 min + 30 min/37°C. |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
50 µL (1:64 dilution) |
Chlamydia IgG Seroelisa |
P2841/96 Wells |
Intended use |
For thequalitative determination of IgG Antibodies to Chlamydia. |
Label |
HRP |
Method |
ELISA |
Controls included |
Three Controls (positive, low positive, negative) |
Incubations |
30 min + 30 min/37°C. |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
50 µL (1:256 dilution) |
Chlamydia IgM Seroelisa |
P2839/96 Wells |
Intended use |
For the qualitative determination of IgM Antibodies to Chlamydia. |
Label |
HRP |
Method |
ELISA |
Controls included |
Two Controls (positive, negative) |
Incubations |
30 min + 30 min/37°C |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
50 µL (1:128 dilution) |
Chlamydia pneumoniae IgA |
CHLA0510/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Chlamydia pneumoniae |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Chlamydia pneumoniae IgG |
CHLG0510/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Chlamydia pneumoniae |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Chlamydia pneumoniae IgM |
CHLM0510/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Chlamydia pneumoniae |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Chlamydia trachomatis IgA |
CHLA00070/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Chlamydia Trachomatis |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Chlamydia trachomatis IgG |
CHLG00070/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Chlamydia Trachomatis |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Chlamydia trachomatis IgM |
CHLM00070/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Chlamydia Trachomatis |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Corynebacterium diphteriae toxin IgG |
CORG0090/96 wells |
Intended use |
For the quantitative determination of IgG antibodies against Corynebacterium diphtheriae toxin IgG (antitoxin) |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Calibrators |
4 vials (0-0.150 IU/mL) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Dengue IgG |
DENG0120/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Dengue Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Dengue IgM |
DENM0120/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Dengue Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Echinococcus IgG |
ECHG0130/96 Wells |
Intended use |
For the qualitative determination of IgG Antibodies against Echinococcus. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
Entamoeba histolytica IgG (Amebiasis) |
ENTG0140/96 Wells |
Intended use |
For the qualitative determination of IgG Antibodies against Entamoeba histolytica. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
Helicobacter pylori IgA |
HELA0220/96 wells |
Intended use |
For the quantitative determination of IgA antibodies against Helicobacter pylori |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Calibrators |
4 (0-150) NTU/mL |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Helicobacter pylori IgG |
HELG0220/96 wells |
Intended use |
For the quantitative determination of IgG antibodies against Helicobacter pylori |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Calibrators |
4 vials (0-150) NTU/mL |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Influenza A IgA |
INFA0290/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Influenza A Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Influenza A IgG |
INFG0290/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Influenza A Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Influenza A IgM |
INFM0290/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Influenza A Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Influenza B IgA |
INFA0300/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Influenza B Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Influenza B IgG |
INFG0300/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Influenza B Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Influenza B IgM |
INFM0300/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Influenza B Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Leishmania infantum |
LEIG0310/96 wells |
Intended use |
For the qualitative determination of IgG Antibodies against Leishmania infantum |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
Measles Virus IgG |
MEAG0330/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Measles Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Measles Virus IgM |
MEAM0330/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Measles Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Mumps Virus IgG |
MUMG0340/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Mumps Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Mumps Virus IgM |
MUMM0340/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Mumps Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Mycoplasma pneumoniae IgG |
MYCG0350/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Mycoplasma pneumoniae |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Mycoplasma pneumoniae IgM |
MYCM0350/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Mycoplasma pneumoniae |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Parainfluenza 1, 2, 3 IgA |
PAIA0360/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Parainfluenza 1, 2, 3 Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Parainfluenza 1, 2, 3 IgG |
PAIG0360/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Parainfluenza 1, 2, 3 Virus. |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Clostridium tetani IgG |
TETG0430/96 wells |
Intended use |
For the quantitative determination of IgG Antibodies against Clostridium tetani toxin (antitoxin). |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Two levels (Positive, Negative) |
Calibrators |
4 (0-1 IU/mL) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
50 µL (1:101) |
Respiratory Syncytial Virus (RSV) IgA |
RSVA0380/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Respiratory Syncytial Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Respiratory Syncytial Virus (RSV) IgG |
RSVG0380/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Respiratory syncytial virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Respiratory Syncytial Virus (RSV) IgM |
RSVM0380/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Respiratory syncytial virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Taenia solium IgG |
TAEG0420/96 wells |
Intended use |
For the qualitative determination of IgG Antibodies against Taenia solium. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
Tick borne Encephalitis (TBE) Virus IgG |
TICG0440/96 wells |
Intended use |
For the quantitative determination of IgG antibodies against TBE Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Calibrators |
5 (0-300 NTU/mL) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Tick borne Encephalitis (TBE) Virus IgM |
TICM0440/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against TBE Virus |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Toxocara canis IgG |
TOCG0450/96 wells |
Intended use |
For the qualitative determination of IgG Antibodies against Toxocara canis. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
Trichinella spiralis IgG |
TRIG0480/96 wells |
Intended use |
For the qualitative determination of IgG Antibodies against Trichinella spiralis. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three levels (Positive, Negative, Cut-off) |
Incubations |
1 h/37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum (1:101) |
ETI-Treponema PLUS |
N0148/96 wells N0149/480 wells |
Intended use |
For the qualitative determination of Total Antibodies against Treponema pallidum |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (high positive, low positive, negative) |
Incubations |
1 h + 30 min/37C° |
Chromogen/Substrate |
TMB |
Sample type |
Serum and plasma |
Sample size |
50 µL (1:2) |
Varicella-Zoster Virus IgA |
VZVA0490/96 wells |
Intended use |
For the qualitative determination of IgA antibodies against Varicella-Zoster Virus (VZV) |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Varicella-Zoster Virus IgG |
VZVG0490/96 wells |
Intended use |
For the qualitative determination of IgG antibodies against Varicella-Zoster Virus (VZV) |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Varicella-Zoster Virus IgM |
VZVM0490/96 wells |
Intended use |
For the qualitative determination of IgM antibodies against Varicella-Zoster Virus (VZV) |
Label |
HRP |
Material provided |
Sufficient for 2x25-30 determinations each |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum |
Sample size |
100 µL (1:101) |


